Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs Newswire.ca - Fri May 23, 8:10AM CDT

/CNW/ -- Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is...

ONCY : 0.9700 (+1.68%)
ACLX : 66.00 (+0.75%)
TCRX : 1.0400 (+14.20%)
ONC.TO : 1.42 (+2.16%)
AKYA : 1.2900 (-5.15%)
QTRX : 6.62 (-0.30%)
Akoya: Q1 Earnings Snapshot AP - Mon May 12, 3:36PM CDT

Akoya: Q1 Earnings Snapshot

AKYA : 1.2900 (-5.15%)
Akoya Biosciences Reports First Quarter 2025 Financial Results GlobeNewswire - Mon May 12, 3:05PM CDT

AKYA : 1.2900 (-5.15%)
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025 GlobeNewswire - Thu Apr 24, 7:00AM CDT

AKYA : 1.2900 (-5.15%)
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas GlobeNewswire - Thu Apr 24, 7:00AM CDT

AKYA : 1.2900 (-5.15%)
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore GlobeNewswire - Wed Apr 23, 7:00AM CDT

AKYA : 1.2900 (-5.15%)
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities GlobeNewswire - Wed Apr 2, 7:00AM CDT

AKYA : 1.2900 (-5.15%)
Akoya: Q4 Earnings Snapshot AP - Mon Mar 17, 3:15PM CDT

Akoya: Q4 Earnings Snapshot

AKYA : 1.2900 (-5.15%)
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results GlobeNewswire - Mon Mar 17, 3:00PM CDT

AKYA : 1.2900 (-5.15%)
QTRX : 6.62 (-0.30%)
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels GlobeNewswire - Wed Feb 5, 7:00AM CST

AKYA : 1.2900 (-5.15%)

Barchart Exclusives

Have a MERRY Christmas With These 9 Unusually Active Options Barchart - 41 minutes ago
In the past year, there have been many interesting stocks and their unusually active options to discuss. Whether you do or don’t celebrate Christmas, here are nine stocks whose unusually active options make for good bets in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot